SCHEMBL1037129

SCHEMBL1037129

NS(=O)(=O)c1cccc2ccoc12

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CA2 P00918 11/20 0.50
CA1 P00915 10/20 0.50
CA9 Q16790 9/20 0.50
MAPK1 P28482 1/20 0.44
CA12 O43570 7/20 0.44
CA6 P23280 3/20 0.41
CA4 P22748 2/20 0.41
CA5A P35218 2/20 0.41
CA7 P43166 2/20 0.41
CA5B Q9Y2D0 2/20 0.41
CYP2C9 P11712 1/20 0.41
CA14 Q9ULX7 1/20 0.41
CDK2 P24941 1/20 0.40
AKT1 P31749 1/20 0.38
PIK3CA P42336 1/20 0.38
MTOR P42345 1/20 0.38
STAT3 P40763 1/20 0.36
PTGES2 Q9H7Z7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1037671 0.82 AKT1 (0.36) CA2CA1CA9MAPK1AKT1
SCHEMBL3791817 0.81 TTR (0.39) CA2CA1CA9MAPK1CA12
Hydrochloric Acid SCHEMBL28047353 0.79 TTR (0.38) CA2CA1CA9MAPK1CA12
SCHEMBL15896279 0.78 CA1 (0.45) CA2CA1AKT1PIK3CAMTOR
SCHEMBL3796728 0.77 MEN1 (0.36) CA2CA1CA9MAPK1CA12
SCHEMBL31525869 0.72 S1PR1 (0.42) CA2CA1CA9MAPK1CA12
SCHEMBL28299617 0.70 CA2 (0.57) CA2CA1CA9MAPK1CA12
SCHEMBL28295349 0.70 CA2 (0.49) CA2CA1CA9MAPK1CA12
SCHEMBL9817877 0.70 CA1 (0.47) CA2CA1CA9CA12CA6
SCHEMBL9569787 0.69 CA2 (0.50) CA2CA1CA9MAPK1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103339132-B Purinylpyridinylamino-2,4-difluorophenyl sulfonamide derivative, pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition with inhibitory activity against raf kinase, containing same as active ingredi 株式会社麦迪帕克特 2017-02-15 CN claimed
CN-103339132-B Purinylpyridinylamino-2,4-difluorophenyl sulfonamide derivative, pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition with inhibitory activity against raf kinase, containing same as active ingredi 株式会社麦迪帕克特 2017-02-15 CN disclosed
EP-2276731-A1 2-SULFONYLAMINO-4-HETEROARYL BUTYRAMIDE ANTAGONISTS OF CCR10 Boehringer Ingelheim International GmbH (DE) 2011-01-26 EP disclosed
WO-2009126675-A1 2-SULFONYLAMINO-4-HETEROARYL BUTYRAMIDE ANTAGONISTS OF CCR10 BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-10-15 WO disclosed
EP-0079683-B1 HERBICIDAL SULFONAMIDES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1987-05-06 EP disclosed